BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

57 related articles for article (PubMed ID: 27567391)

  • 1. Characteristics and outcomes of Indian children enrolled in a rheumatic heart disease registry.
    Mehta A; Saxena A; Juneja R; Ramakrishnan S; Gupta S; Kothari SS
    Int J Cardiol; 2016 Nov; 222():1136-1140. PubMed ID: 27567391
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Latent Rheumatic Heart Disease: Identifying the Children at Highest Risk of Unfavorable Outcome.
    Beaton A; Aliku T; Dewyer A; Jacobs M; Jiang J; Longenecker CT; Lubega S; McCarter R; Mirabel M; Mirembe G; Namuyonga J; Okello E; Scheel A; Tenywa E; Sable C; Lwabi P
    Circulation; 2017 Dec; 136(23):2233-2244. PubMed ID: 28972003
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rheumatic heart disease in Uganda: predictors of morbidity and mortality one year after presentation.
    Okello E; Longenecker CT; Beaton A; Kamya MR; Lwabi P
    BMC Cardiovasc Disord; 2017 Jan; 17(1):20. PubMed ID: 28061759
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence, clinical characteristics and echocardiographic parameters of arrhythmias among patients with rheumatic heart disease attending Jakaya Kikwete Cardiac Institute: a prospective cohort study.
    Makatu CD; Mutagaywa RK; Peter P; Barongo A; Kifai E
    BMC Cardiovasc Disord; 2023 Aug; 23(1):403. PubMed ID: 37592207
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Echo-based screening of rheumatic heart disease in children: a cost-effectiveness Markov model.
    Zachariah JP; Samnaliev M
    J Med Econ; 2015 Jun; 18(6):410-9. PubMed ID: 25629653
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The burden of rheumatic heart disease among children in Lagos: how are we fairing?
    Animasahun BA; Madise Wobo AD; Itiola AY; Adekunle MO; Kusimo OY; Thomas FB
    Pan Afr Med J; 2018; 29():150. PubMed ID: 30050614
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intramuscular versus enteral penicillin prophylaxis to prevent progression of rheumatic heart disease: Study protocol for a noninferiority randomized trial (the GOALIE trial).
    Rwebembera J; Ndagire E; Carvalho N; Webel AR; Sable C; Okello E; Sarnacki R; Spaziani AM; Mucunguzi A; Engelman D; Grobler A; Steer A; Beaton A
    Am Heart J; 2024 May; 275():74-85. PubMed ID: 38797460
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Outcomes and Care Quality Metrics for Women of Reproductive Age Living With Rheumatic Heart Disease in Uganda.
    Chang AY; Nabbaale J; Okello E; Ssinabulya I; Barry M; Beaton AZ; Webel AR; Longenecker CT
    J Am Heart Assoc; 2020 Apr; 9(8):e015562. PubMed ID: 32295465
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Outcomes for patients with rheumatic heart disease after cardiac surgery followed at rural district hospitals in Rwanda.
    Rusingiza EK; El-Khatib Z; Hedt-Gauthier B; Ngoga G; Dusabeyezu S; Tapela N; Mutumbira C; Mutabazi F; Harelimana E; Mucumbitsi J; Kwan GF; Bukhman G
    Heart; 2018 Oct; 104(20):1707-1713. PubMed ID: 29678896
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The clinical characteristics of adults with rheumatic heart disease in Yangon, Myanmar: An observational study.
    Myint NPST; Aung NM; Win MS; Htut TY; Ralph AP; Cooper DA; Nyein ML; Kyi MM; Hanson J
    PLoS One; 2018; 13(2):e0192880. PubMed ID: 29466408
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical outcomes of children with rheumatic heart disease.
    Zimmerman M; Kitooleko S; Okello E; Ollberding N; Sinha P; Mwambu T; Sable C; Beaton A; Longenecker C; Lwabi P
    Heart; 2022 Apr; 108(8):633-638. PubMed ID: 35110387
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluating the implementation of a dynamic digital application to enable community-based decentralisation of rheumatic heart disease case management in Uganda: protocol for a hybrid type III effectiveness-implementation study.
    Minja NW; Pulle J; Rwebembera J; de Loizaga SR; Fall N; Ollberding N; Abrams J; Atala J; Kamarembo J; Oyella L; Odong F; Nalubwama H; Nakagaayi D; Sarnacki R; Su Y; Dexheimer JW; Sable C; Longenecker CT; Danforth K; Okello E; Beaton AZ; Watkins DA
    BMJ Open; 2023 Oct; 13(10):e071540. PubMed ID: 37898491
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Secondary prophylaxis to control rheumatic heart disease in developing countries: Put into a cage if can't be killed.
    Barik R
    Indian Heart J; 2018; 70(6):907-910. PubMed ID: 30580864
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rheumatic Heart Disease Patients' Adherence to Secondary Prophylaxis and Associated Factors at Hospitals in Jimma Zone, Southwest Ethiopia: A Multicenter Study.
    Adem A; Dukessa Gemechu T; Jarso H; Reta W
    Patient Prefer Adherence; 2020; 14():2399-2406. PubMed ID: 33304095
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Throat Colonization and Antibiotic Susceptibility of Group a β-Hemolytic Streptococci Among Rheumatic Heart Disease Patients Attending a Cardiac Referral Hospital in Tanzania, a Descriptive Cross-Sectional Study.
    Wangilisasi S; Chillo P; Kimambo D; Janabi M; Kamuhabwa A
    Front Surg; 2020; 7():57. PubMed ID: 33094103
    [No Abstract]   [Full Text] [Related]  

  • 16. Mortality and Morbidity in Adults With Rheumatic Heart Disease.
    Karthikeyan G; Ntsekhe M; Islam S; Rangarajan S; Avezum A; Benz A; Cabral TTJ; Changsheng M; Chillo P; Gonzalez-Hermosillo JA; Gitura B; Damasceno A; Dans AML; Davletov K; Elghamrawy A; ElSayed A; Fana GT; Gondwe L; Haileamlak A; Kayani AM; Lwabi P; Maklady F; Molefe-Baikai OJ; Musuku J; Ogah OS; Paniagua M; Rusingiza E; Sharma SK; Zuhlke L; Connolly S; Yusuf S;
    JAMA; 2024 Jun; ():. PubMed ID: 38837131
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Current status of rheumatic heart disease in India.
    Negi PC; Sondhi S; Asotra S; Mahajan K; Mehta A
    Indian Heart J; 2019; 71(1):85-90. PubMed ID: 31000189
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Aswan Rheumatic heart disease reGIstry: rationale and preliminary results of the ARGI database.
    Kotit S; Yacoub MH
    Front Cardiovasc Med; 2023; 10():1230965. PubMed ID: 37795482
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment adherence and its determinants among the rheumatic fever/rheumatic heart disease patients during COVID 19 pandemic - A cross sectional study from Chandigarh, India.
    Ilanchoorian D; Thakur JS; Vijayvergiya R; Jindal AK; Gandhi A; Sagar V
    J Family Med Prim Care; 2023 Dec; 12(12):3254-3261. PubMed ID: 38361873
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pre-intervention wait time and survival in people with rheumatic heart disease in Uganda.
    Doh CY; An C; Chang AY; Rwebembera J; Mwambu TP; Beaton AZ; Nakagaayi D; Ruda Vega PF; Sable CA; Longenecker CT; Lwabi P
    Ann Thorac Surg; 2024 Jun; ():. PubMed ID: 38908768
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.